AAAAAA

   
Results: 1-9 |
Results: 9
REPEAT WHOLE-CELL VACCINATIONS SHOULD BE AVOIDED AFTER HYPOTONIC-HYPORESPONSIVE EPISODES
Authors: TOZZI AE DEGLIATTI MLC SALMASO S ANEMONA A
Citation: Ae. Tozzi et al., REPEAT WHOLE-CELL VACCINATIONS SHOULD BE AVOIDED AFTER HYPOTONIC-HYPORESPONSIVE EPISODES, BMJ. British medical journal, 317(7158), 1998, pp. 604-604
PREDICTORS OF ADVERSE EVENTS AFTER THE ADMINISTRATION OF ACELLULAR AND WHOLE-CELL DIPHTHERIA-TETANUS-PERTUSSIS VACCINES
Authors: TOZZI AE DEGLIATTI MLC WASSILAK SGF SALMASO S PANEI P ANEMONA A LUZI S GRECO D
Citation: Ae. Tozzi et al., PREDICTORS OF ADVERSE EVENTS AFTER THE ADMINISTRATION OF ACELLULAR AND WHOLE-CELL DIPHTHERIA-TETANUS-PERTUSSIS VACCINES, Vaccine, 16(2-3), 1998, pp. 320-322
PERSISTENCE OF PROTECTION THROUGH 33 MONTHS OF AGE PROVIDED BY IMMUNIZATION IN INFANCY WITH 2 3-COMPONENT ACELLULAR PERTUSSIS VACCINES
Authors: SALMASO S MASTRANTONIO P WASSILAK SGF GIULIANO M ANEMONA A GIAMMANCO A TOZZI AE DEGLIATTI MLC GRECO D
Citation: S. Salmaso et al., PERSISTENCE OF PROTECTION THROUGH 33 MONTHS OF AGE PROVIDED BY IMMUNIZATION IN INFANCY WITH 2 3-COMPONENT ACELLULAR PERTUSSIS VACCINES, Vaccine, 16(13), 1998, pp. 1270-1275
BORDETELLA-PARAPERTUSSIS INFECTION IN CHILDREN - EPIDEMIOLOGY, CLINICAL SYMPTOMS, AND MOLECULAR CHARACTERISTICS OF ISOLATES
Authors: MASTRANTONIO P STEFANELLI P GIULIANO M ROJAS YH DEGLIATTI MC ANEMONA A TOZZI AE
Citation: P. Mastrantonio et al., BORDETELLA-PARAPERTUSSIS INFECTION IN CHILDREN - EPIDEMIOLOGY, CLINICAL SYMPTOMS, AND MOLECULAR CHARACTERISTICS OF ISOLATES, Journal of clinical microbiology, 36(4), 1998, pp. 999-1002
INCIDENCE OF INVASIVE HAEMOPHILUS-INFLUENZAE TYPE-B DISEASE IN ITALIAN CHILDREN
Authors: TOZZI AE SALMASO S DEGLIATTI MLC PANEI P ANEMONA A SCUDERI G WASSILAK SGF
Citation: Ae. Tozzi et al., INCIDENCE OF INVASIVE HAEMOPHILUS-INFLUENZAE TYPE-B DISEASE IN ITALIAN CHILDREN, European journal of epidemiology, 13(1), 1997, pp. 73-77
PREDICTING THE ACCRUAL RATE IN A VACCINE CLINICAL-TRIAL - AN A-POSTERIORI EVALUATION OF THE FEASIBILITY STUDY
Authors: TOZZI AE ATTI MLCD PANEI P ANEMONA A BINKIN N SALMASO S LUZI S GRECO D
Citation: Ae. Tozzi et al., PREDICTING THE ACCRUAL RATE IN A VACCINE CLINICAL-TRIAL - AN A-POSTERIORI EVALUATION OF THE FEASIBILITY STUDY, Revue d'epidemiologie et de sante publique, 44(5), 1996, pp. 387-393
A DIFFERENCE IN RELATIVE EFFICACY OF 2 DTAP VACCINES IN CONTINUED BLINDED OBSERVATION OF CHILDREN FOLLOWING A CLINICAL-TRIAL
Authors: GRECO D SALMASO S MASTRANTONIO P GIULIANO M GIAMMANCO A STEFANELLI P ANEMONA A TOZZI AE ATTI MCD PANEI P WASSILAK SG
Citation: D. Greco et al., A DIFFERENCE IN RELATIVE EFFICACY OF 2 DTAP VACCINES IN CONTINUED BLINDED OBSERVATION OF CHILDREN FOLLOWING A CLINICAL-TRIAL, Pediatric research, 39(4), 1996, pp. 1021-1021
A CONTROLLED TRIAL OF 2 ACELLULAR VACCINES AND ONE WHOLE-CELL VACCINEAGAINST PERTUSSIS
Authors: GRECO D SALMASO S MASTRANTONIO P GIULIANO M TOZZI AE ANEMONA A ATTI MLCD GIAMMANCO A PANEI P BLACKWELDER WC KLEIN DL WASSILAK SGF STEFANELLI P BOTTONE M SOFIA T LUZI S BELLOMI G COBIANCHI F CANGANELLA G MEDURI F SCUDERI G CHIARINI A MAGGIO M TAORMINA S GENOVESE M MOIRAGHI A BARALE A DITOMMASO S MALASPINA S VASILE E FERRARO P DALLAGO P DEMARZI L ROBINO L GIRALDO E COPPOLA N MATERASSI P CASTELLANI GT BASSO F BARBUTI S QUARTO M LOPALCO P DORAZIO P SANGUEDOLCE A
Citation: D. Greco et al., A CONTROLLED TRIAL OF 2 ACELLULAR VACCINES AND ONE WHOLE-CELL VACCINEAGAINST PERTUSSIS, The New England journal of medicine, 334(6), 1996, pp. 341-348
HIV PREVALENCE AND FREQUENCY OF RISK BEHAVIOR IN INJECTING DRUG-USERSENTERING TREATMENT AND OUT OF TREATMENT - A CROSS-SECTIONAL STUDY IN 5 ITALIAN CITIES
Authors: REZZA G SALMASO S ABENI D BRANCATO G ANEMONA A ROVETTA C VERANI P PERUCCI CA CARBALLO M SERPELLONI G GALVAN U MANCONI PE MELONI D PIRO R SOLINAS C PETRELLA M NESPOLI M LAZZARIN A ZANON L ZAMPIERI F
Citation: G. Rezza et al., HIV PREVALENCE AND FREQUENCY OF RISK BEHAVIOR IN INJECTING DRUG-USERSENTERING TREATMENT AND OUT OF TREATMENT - A CROSS-SECTIONAL STUDY IN 5 ITALIAN CITIES, Journal of drug issues, 24(3), 1994, pp. 527-535
Risultati: 1-9 |